Last reviewed · How we verify
NCT04050514
Side Effects of Mandibular Advancement Devices
NA trial testing H-MAD with a hinge system according to Herbst in Obstructive Sleep Apnea Syndrome in 65 participants. Completed in 21 December 2022.
1 December 2022
Quick facts
| Lead sponsor | University Medicine Greifswald |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 65 |
| Start date | 1 December 2019 |
| Primary completion | 1 December 2022 |
| Estimated completion | 21 December 2022 |
| Sites | 9 locations across Germany |
Drugs / interventions tested
- H-MAD with a hinge system according to Herbst
Conditions studied
- Obstructive Sleep Apnea Syndrome — all drugs for Obstructive Sleep Apnea Syndrome →
- Temporomandibular Disorders — all drugs for Temporomandibular Disorders →
Sponsor
University Medicine Greifswald
Who can join
Adults 18 to 75, any sex, with Obstructive Sleep Apnea Syndrome or Temporomandibular Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Sleep-related breathing disorders (SBAS) are one of the most common causes of non-restorative sleep. Sleep therapy options include positive pressure ventilation with continuous positive airway pressure (CPAP) masks, mandibular advancement of the mandible with mandibular advancement devices (MAD), back restraining, weight reduction, ear, nose and throat surgical procedures, bimaxillary or mandibular remodeling osteotomies, and neurostimulation procedures N. hypoglossal. In mild to moderate obstructive sleep apnea syndrome (OSAS), MAD, back suppression and weight reduction are potential treatment options. This study aims to identify possible side effects in the temporomandibular system that occur during nocturnal support of a mandibular arch over two years. Two different MADs are compared in terms of construction, height (bite elevation) and protrusion mechanics: the H-MAD with an hinge system according to Herbst and the SomnoDent Fusion ™ MAD (called F-MAD) with sliding side wings. In addition, it is to be evaluated whether hinge system according to Herbst as a protrusion-controlling element and the reduction of the splint body for a reduced bite elevation leads to a significant reduction of side effects compared to the F-MAD.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Side effects of mandibular advancement devices in obstructive sleep apnea patients - observational results of a randomized controlled trial.
Bernhardt O, Giannakopoulos NN, Kares H, Meyer A, et al · · 2026 · PMID 41634250 · DOI 10.1007/s11325-026-03576-4
Verify or expand the search:
- PubMed search for NCT04050514
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obstructive Sleep Apnea Syndrome
Currently open trials in the same condition.
- NCT05147649 — Functional Magnetic Resonance Imaging in Patients With Obstructive Sleep Apnea Syndrome · NA · recruiting
Other University Medicine Greifswald trials
Trials by the same sponsor.
- NCT06796374 — A Comparison of Fisetin Kinetics in Young and Old Adults · NA · recruiting
- NCT06970171 — Acceptance of Mandibular Advancement Devices · NA · not yet recruiting
- NCT06939608 — Kinetics of Yohimbine in Humans to Explore Sex and CYP2D6 Genotype Interactions · NA · completed
- NCT06273241 — Impact of Food Intake on Berberine Kinetics · NA · completed
- NCT06249451 — Staphylococcus Aureus Bacteraemia (SAB)-Support-Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04050514 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Medicine Greifswald
- Last refreshed: 15 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04050514.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing